Company: LNAI
Filing Date: 2025-07-30
Form Type: DEF 14A
Source: 0001731122-25-001053
Chunk: 18

Company: Lunai Bioworks Inc.
Filing Date: 2025-07-30
Form: DEF 14A
Chunk 18
---
, including the
historical and projected performance of our common stock, prevailing market conditions and general economic trends, and will place
emphasis on the expected closing price of our common stock in the period following the effectiveness of the Reverse Split. Our Board
will also consider the impact of the Approved Split Ratios on investor interest. The purpose of selecting a range is to give our
Board the flexibility to meet business needs as they arise, to take advantage of favorable opportunities and to respond to a
changing corporate environment. Based on the number of shares of common stock issued and outstanding as of August 15, 2025
after completion of the Reverse Split, we will have between 76,976,321 and 23,092,896 shares of common stock issued and outstanding,
depending on the Final Split Ratio selected by our Board.

Principal Effects of the Reverse Split

After the effective date
of the Reverse Split, each stockholder will own a reduced number of shares of common stock. Except for adjustments that may result from
the treatment of fractional shares as described below, the proposed Reverse Split will affect all stockholders uniformly. The proportionate
voting rights and other rights and preferences of the holders of our common stock will not be affected by the Reverse Split (other than
as a result of the payment of cash in lieu of fractional shares). For example, a holder of 2% of the voting power of the outstanding shares
of our common stock immediately prior to a Reverse Split would continue to hold 2% of the voting power of the outstanding shares of our
common stock immediately after such Reverse Split. The number of stockholders of record also will not be affected by the Reverse Split,
except to the extent that any stockholder holds only a fractional share interest and receives cash for such interest after the Reverse
Split.

The following table contains approximate
number of issued and outstanding shares of common stock, and the estimated per share trading price following a 1:3 to 1:10 Reverse Split,
without giving effect to any adjustments for fractional shares of common stock or the issuance of any derivative securities, as of July 15,
2025.

<div align='center'>11</div>

After Each Reverse Split Ratio

|                                                                            |     | Current |             |     | 1:03 |             |     | 1:10 |             |
| Common Stock Authorized                                                    |     |         | 350,000,000 |     |      | 350,000,000 |     |      | 350,